Suchergebnisse - "Joerg, Vincent"

PubPharm (14)

1

Corrigendum : PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

enthalten in: Frontiers in immunology | 2024

von Kocheise, L. | Piseddu, I. | Vonderlin, J. | +22

ErratumFor: Front Immunol. 2024 Jan 10;14:1326078. - PMID 38268921

2

PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

enthalten in: Frontiers in immunology | 10 January 2024

von Kocheise, L. | Piseddu, I. | Vonderlin, J. | +22

3

Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

enthalten in: Frontiers in immunology | 24 January 2024

von Kocheise, L. | Piseddu, I. | Vonderlin, J. | +22

4

EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma

enthalten in: Scientific reports | 2023

von Kocheise, L. | Schoenlein, M. | Behrends, B. | +13

5

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy : A global, observational study

enthalten in: Hepatology communications | 2023

von Joerg, V. | Scheiner, B. | D Alessio, A. | +33

6

PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune liver disease

enthalten in: bioRxiv.org | 2023

von Kocheise, L. | Piseddu, I. | Vonderlin, J. | +22

7

PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

enthalten in: Frontiers in immunology | 2023

von Kocheise, L. | Piseddu, I. | Vonderlin, J. | +22

ErratumIn: Front Immunol. 2024 Jan 24;15:1369747. - PMID 38327519

8

Targeting cyclin-dependent kinase 7-association between CDK7 and pMED1 expression in prostate cancer tissue

enthalten in: Carcinogenesis | 2022

von Paulsen, F. | Kang, D. | Becker, F. | +10

9

Up-regulation of POM121 is linked to prostate cancer aggressiveness and serves as a prognostic biomarker

enthalten in: Urologic oncology | 2022

von Becker, F. | Offermann, A. | Roesch, M. | +8

10

Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer

enthalten in: The American journal of pathology | 2022

von Offermann, A. | Joerg, V. | Becker, F. | +11